A Message from the AAAAI

Addressing Practice Viability Video

As the coronavirus disease 2019 (COVID-19) spreads across the globe, we recognize the importance of our roles as healthcare providers, particularly to patients known for asthma, other allergic conditions, or immune deficiencies who may be at a higher risk of experiencing severe symptoms from the disease. The same way that you are committed to your patients, practices, and communities, we at the AAAAI remain committed to providing you with resources that will help you navigate this difficult period.

Because this is an evolving situation, we invite you to bookmark this page and check it often. We will be continually adding resources.

If you have any specific questions regarding the treatment of patients or management of your practice, please contact us at practicematters@aaaai.org.

Important Update Symbol Read all messages from the AAAAI COVID-19 Response Task Force

Special Article: COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic

Click here to download the special article as a PDF.

This special article is designed to help you determine how best to prioritize and triage your patients during this crisis, including:

  • Condition-specific guidance for service reduction and patient prioritization
  • Opportunities for providing care utilizing telemedicine
  • Suggestions for communicating with your patients with regards to office policies and changes

Disclaimer: This article was prepared as a service to the public and is only intended to be a general summary of the subject matter contained therein for general informational purposes only.  Read the full disclaimer here.

Twitter Chat
Dr. Dave Stukus, one of the authors of the Special Article, and Dr. Ann Wu, the JACI: In Practice Social Media Coordinator, led a Twitter Chat about this special article. Read the tweets #JACIIPCOVID.

Resources for A/I Clinicians

Prepare Your Practice                  Utilize Telemedicine                  Important Updates Image

AAAAI Original Resources

Written Resources

Important Update Symbol AAAAI COVID-19 Advocacy 

An Update on COVID-19 for the Practicing Allergist/immunologist (3/30/20)

Advice from a COVID-19 Epi-Center: How One Allergy/Immunology Practice is Navigating the Pandemic (3/19/20)

Coding Specific to Coronavirus Diagnosis, Testing and Telemedicine (4/2/20)

Coronavirus Disease 2019 (COVID-19) with a Focus on Older Adults: A Guide for Allergist/ and Immunologists and Patients (3/16/20)

Immunotherapy during the COVID-19 Pandemic: a Work Group Report on Administration of Subcutaneous Allergen Immunotherapy from the AAAAI IASAD Committee (3/25/20)

Podcast EpisodesConversations from the World of Allergy Logo

Episode 26: Latest Update on COVID-19: What Physicians and Patients Need to Know (3/17/20)
Two global health experts, Daniel Lucey, MD, MPH and George Anesi, MD, MSCE, MBE, discuss the most up to date information regarding COVID-19. Listen now to learn about preparedness and how this pandemic can specifically impact patients with asthma, allergies and immune deficiency.

Episode 25: Coronavirus Disease 2019 (COVID-19) Update: What Healthcare Professionals and Patients Need to Know (3/3/20)
This AAAAI Hot Topics podcast episode with virus expert Mitchell Grayson, MD, FAAAAI discusses specific issues for patients with asthma and allergic disease and is a must listen for physicians, their staff and their patients.

Keep Your Patients Informed

About Changes to your Practice

Communication with patients is key during this time. Use your practice website, practice portal and established social media channels to communicate information regularly. Keep them informed of any potential changes to your policies on appointments, providing non urgent care, your availability via telemedicine platforms, etc.

About COVID-19

Provide links to high quality information from trusted health resources, including local resources.

Symptoms Comparison Chart

About Protecting Themselves

 COVID-19 and Asthma Infographic for Patients              Protect Yourself from COVID-19 Infographic

5 Things to Keep in Mind during the COVID-19 Pandemic             Advice for High Risk Individuals

Ask the AAAAI about COVID-19

Important Update Symbol The AAAAI invites you to send your COVID-19 questions to practicematters@aaaai.org. Questions and responses that might be helpful for a wider audience are provided in the links below.

Administering Immunotherapy

Asthma

Immunocompromised Patients

Other Important Issues

Ask Us - Email practicematters@aaaai.org

Links to Helpful Resources

Ongoing Series for Physicians

Important Update Symbol CDC: Clinician Outreach and Communication Activity (COCA)

Important Update Symbol CMS: Lessons from The Front Lines: COVID-19 

Web Resources

Important Update Symbol  JACI has just published an online article, "Running a virtual allergy division and training program in the time of COVID-19 pandemic."

The ACCME is maintaining a list of accredited CME activities and resources related to COVID-19.

Joint Statement from the AMA, APA, and ASHP on inappropriate ordering, prescribing or dispensing of medications to treat COVID-19. (3/25/20)

    The AMA's physician guide to COVID-19 provides a wealth of links and resources, including:

    • facility preparedness guidelines 
    • patient handouts
    • how to proceed if you have been exposed to patients with COVID-19.

    The American College of Physicians's COVID-19: Information for Internists site includes numerous resources, such as:

    • An interactive physician's guide that carries CME/MOC credit 
    • Podcast episodes from the Infectious Diseases Society of America (IDSA)
    • Highlighted articles from Annals of Internal Medicine regarding COVID-19

    The CDC's coronavirus disease hub includes:

    • situation updates
    • information from the White House Coronavirus Task Force
    • information for health care professionals and patients

    Elsevier's Novel Coronavirus Information Center hosts COVID-19 papers that are free to access. It includes tabs for:

    • expert guidance
    • clinician information
    • research/drug discovery

    The FDA has issued guidance for conducting clinical trials during the pandemic.

    USP's Compounding Standards page includes links to:

    • updated USP statement on Compounding Alcohol-Based Hand Sanitizer
    • USP Response to Shortages of Garb and PPE for Sterile Compounding
    • selected USP-NF resources on the development of vaccines and antiviral medicines